The Population Council, Inc.

Laboratoire Hra-pharma

Yun-Yen Tsong

Gursaran P Talwar

Regine Sitruk-Ware

Anna E Ladd

Samuel Koide

Rosemarie B Thau

Sheldon J Segal

Disclosed are sustained release compositions for vaginal or transdermal administration that contain a progesterone receptor modulator such as CDB-2914 (also referred to as VA-2914), and methods of using them for long term contraception or therapeutic purposes. Also disclosed are methods for making the compositions.

Sustained release compositions containing progesterone receptor modulators

The present prevention provides an effective, fast acting method of vaccination useful in suppressing gonadotropic hormone release. The vaccine utilizes LHRH conjugated at its amino terminus to a protein carrier and can be mixed with either adjuvants or detergents in order to provide an effect vaccine.

[Gln']-luteinizing hormone releasing hormone conjugate of tetanus

Method of purifying the beta sub-unit of chorionic gondotropin which includes contacting a preparation of the beta sub-unit of chorionic gonadotropin with an insolubilized anti alpha sub-unit of chorionic gondotropin serum and the highly purified beta sub-unit of chorionic gonadotropin obtained by this method.

Beta-hCG preparation and method

Growing community of inventors

North Caldwell, NJ, United States of America

Yun-Yen Tsong